Serbia vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Serbia
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Serbia rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Serbia
- South-East Asia (WHO region)
How they compare
Serbia currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Serbia's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 17 years both countries report, Serbia has been ahead every year.
Serbia ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Serbia | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 28.9% | 71.1% | Serbia |
| 2010s | 100.0% | 76.0% | 24.0% | Serbia |
| 2020s | 100.0% | 94.0% | 6.0% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Serbia or South-East Asia (WHO region)?
- Serbia, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Serbia and South-East Asia (WHO region)?
- 6.0%, with Serbia ahead.
- How many years of comparable data are there for Serbia and South-East Asia (WHO region)?
- 17 years are reported by both, from 2005 to 2024.
- How do Serbia and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Serbia ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.